Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD79B Gene Mutation”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)UnknownNCT04994626
What this trial is testing

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

Who this might be right for
DLBCLMYD88 Gene MutationCD79A Gene Mutation+3 more
Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT06846463
What this trial is testing

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Who this might be right for
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University 21
Testing effectiveness (Phase 2)Temporarily pausedNCT04668365
What this trial is testing

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaCD79A Gene MutationCD79B Gene Mutation
Henan Cancer Hospital 59